Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 114, 164-173
Abstract
No abstract availableKeywords
Funding Information
- General Research Fund (17115017)
This publication has 46 references indexed in Scilit:
- An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current StatusSeminars in Oncology, 2011
- Cognitive Dysfunction Among Cancer SurvivorsAmerican Journal of Physical Medicine & Rehabilitation, 2011
- Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent researchNeuroscience & Biobehavioral Reviews, 2011
- Neurocognitive Dimensions of Breast Cancer and Its TreatmentNeuropsychopharmacology, 2010
- Peroxisome Proliferator-Activated Receptor -β/δ, -γAgonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative MetabolismPPAR Research, 2010
- GABAA and strychnine-sensitive glycine receptors modulate N-methyl-d-aspartate–evoked acetylcholine release from rat spinal motoneurons: A possible role in neuroprotectionNeuroscience, 2008
- Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effectsBreast Cancer Research and Treatment, 2008
- Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptorsJournal of Neurochemistry, 2007
- Neuroprotective Effects of Resveratrol against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress in RatsPharmacology, 2006
- NF-κB functions in synaptic signaling and behaviorNature Neuroscience, 2003